Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research

Michelle Long Schoettler(Children's Healthcare of Atlanta), Sumithira Vasu(The Ohio State University), Paul A. Carpenter(Fred Hutch Cancer Center), Enric Carreras(Hospital Clínic de Barcelona), John Koreth(Otsuka (Japan)), Isabel Sánchez‐Ortega(European Society for Blood and Marrow Transplantation), Alok Srivastava(Aichi Medical University), N. Kroger(The Ohio State University), I. Moissev(First Pavlov State Medical University of St. Petersburg), Kristin Page(Medical College of Wisconsin), V.T. Ho(Dana-Farber Cancer Institute), Byung‐Sik Cho(The Korean Society of Blood and Marrow Transplantation), Christopher E. Dandoy(Cincinnati Children's Hospital Medical Center), Uday Popat(The University of Texas MD Anderson Cancer Center), Robert J. Soiffer(Dana-Farber Cancer Institute), Anna Sureda(Institut Català d'Oncologia), Per Ljungman(Leiden University Medical Center), BE. Shaw(Medical College of Wisconsin), Yoshiko Atsuta(Aichi Medical University), Sonata Jodele(Cincinnati Children's Hospital Medical Center)
Transplantation and Cellular Therapy
November 25, 2022
Cited by 130


Related Papers